Valvular heart disease in women;Enfermedad valvular en mujeres

Revista Espanola de Cardiologia

Volumn 59, Issue 8, 2006, Pages 832-836

  Tornos, Pilar ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Cardiac surgery; Female sex; Valvular heart disease

Indexed keywords

ANTICOAGULANT AGENT;

AORTA STENOSIS; ARTICLE; CALCIFICATION; CORONARY ARTERY SURGERY; DISEASE SEVERITY; EMBRYOPATHY; FEMALE; FIRST TRIMESTER PREGNANCY; HEART MUSCLE CONTRACTILITY; HEART SURGERY; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; INTRACARDIAC THROMBOSIS; MEDICAL RESEARCH; MITRAL VALVE STENOSIS; MORTALITY; PATHOPHYSIOLOGY; PREGNANCY; PREVALENCE; PROGNOSIS; RHEUMATIC HEART DISEASE; RISK ASSESSMENT; SEX DIFFERENCE; VALVULAR HEART DISEASE;

EID: 33749605655     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13091887     Document Type: Article

References (34)

1. Soler Soler J, Galve E. Valve disease. Worldwide perspective of valve disease. Heart. 2000;83:721-5.
2. Khan MA, Herzog CA, Peter JV, Hartley GG, Madlon-Kay R, Dick CD, et al. The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs. N Engl J Med. 1998; 339:713-8.
3. Galve E, Ordi J, Barquinero J, Evangelista A, Vilardell M, Soler-Soler J. Valvular heart disease in the primary antiphospholipid syndrome. Ann Intern Med. 1992; 116:293-8.
4. Acierno LJ. Cardiac complications in acquired immunodeficiency syndrome (AIDS): a review. J Am Coll Cardiol. 1989:13:1144-54.
5. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231-43
6. Roberts WC, Virmani R. Aschoff bodies at necropsy in valvular heart disease. Evidence from an analysis of 543 patients over 14 years of age that rheumatic heart disease, at least anatomically, is a disease of the mitral valve. Circulation. 1978;57:803-7.
7. Zuppiroli A, Rinaldi M, Kramer-Fox R, Favilli S, Roman MJ, Devereux RB. Natural history of mitralvalve prolapse. Am J Cardiol. 1995;15:1028-32.
8. Avierinos JF, Gersh BJ, Melton LJ3rd, Bailey KR, Shub C, Nishimura RA, et al. Natural history of asymptomatic mitral valve prolapse in the community. Circulation. 2002;106:1355-61.
9. Devereux RB, Jones EC, Roman MJ, Howard BV, Fabsitz RR, Liu JE, et al. Prevalence and correlates of mitral valve prolapse in a population-based sample of American Indians: the Strong Heart Study. Am J Med. 2001;111:679-85.
10. Singh RC, Cappucci R, Kramer Fox R, Roman MJ, Kligfield P, Borer JS, et al. Severe mitral regurgitation due to mitral valve prolapse: risk factors for development, progression and need for mitral valve surgery. Am J Cardiol. 2000;85:193-8.
11. Boon A, Cheriex E, Lodder J, Kessels F. Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve. Heats 1997;78:472-4.
12. Fox CS, Vassan RS, Parise H, et al. Mitral annular calcification predicts cardiovascular morbidiy and mortality: The Framingham Heart Study. Circulation. 2003;107:1492-6.
13. Sabet HY, Edwards WD, Tazelaar HD, Daly RC. Congenitally bicuspid aortic valves: a surgical pathology study of 542 cases (1991 through 1996) and a literature review of 2715 additional cases. Mayo Clin Proc. 1999;74:14-26.
14. Tornos P, Olona M, Permanyer G, González T, Carballo J, Pahissa A, et al. Clinical outcome of severe assymptomatic chronic aortic regurgitation: a long-term prospective follow-up study. Am Heart J. 1995;130:333-9.
15. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, et al. Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol. 1997;29:630-4.
16. Ortlepp JR, Schmitz F, Mevissen V, Weiss S, Huster J, Dronskowski R. The amount of calcium-defficient hexagonal hidroxyapatite in aortic valves is influenced by gender and associated with genetic polimorphims in patients with severe calcific aortic stenosis. Eur Heart J. 2004; 25:514-22.
17. Roberts WC, Jong M. Relation of weights of operatively excised stenotic aortic valves to preoperative transvalvular peak systolic pressure gradients and to calculated aortic valve areas. J Am Coll Cardiol. 2004;44:1847-55.
18. Carroll JD, Carroll EP, Feldman T, Ward DM, Lang RM, McGaughey D, et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation. 1992; 86:1099-107.
19. Brandrup-Wognsen G, Berggren H, Hartford M, Hjamarson A, Karlsson T, Herlitz J. Female sex is associated with increased mortality and morbidity early, but not late, after coronary artery bypass grafting. Eur Heart J. 1996;17:1426-31.
20. Blankstein R, Ward RP, Arnsdorf M, Jones B, Lou YB, Pine M. Female gender is an independent predictor of operative mortality after coronary artery bypass graft surgery: contemporary analysis of 31 Midwestern hospitals. Circulation. 2005;112 Suppl 9: I323-7.
21. Roques F, Nashef SAM, Michel P, Gauducheau E, De Vincentiis C, Baudet E, et al. Risk factors and outcome in European cardiac surgery: analysis of the euroSCORE multinational database of 19030 patients. Eur J Cardiovasc Surg. 1999;15:816-23.
22. Rankin JS, Hammill BG, Ferguson TB Jr, Glower DD, O'Brien SM, DeLong ER, et al. Determinants of operative mortality in valvular heart surgery. J Thorac Cardiovasc Surg. 2006;131:547-57.
23. Klodas E, Enríquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB. Surgery for aortic regurgitation in women. Contrasting indications and outcomes compared with men. Circulation. 1996;94:2472-8.
24. Thorne SA. Pregnancy in valve disease. Heart. 2004;90:450-6.
25. Oakley C, Child A, Iung B, et al. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J. 2003;24:761-81.
26. Siu SC, Sermer M, Harrison DA, Grigoriadis E, Liu G, Sorensen S, et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation. 1997;96:2789-94.
27. Rossiter JP, Repke JT, Morales AJ, Murphy EA, Pyeritz RE. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obst Gynecol. 1995;173:1599-606.
28. Lung B, Gohlke-Barwolf C, Tornos P, Tribouilloy C, Hall R, Butchart E, et al; Working Group on Valvular Heart Disease. Recommendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J. 2002;23:1252-66.
29. Rahimtoola SJ. Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol. 2003;41:893-904.
30. De Andrade J, Maldonado M, Pontes JR, Elmec R, De Sousa E. The role of mitral valve balloon valvuloplasty in the treatment of rheumatic mitral valve stenosis during pregnancy. Rev Esp Cardiol. 2001;54:573-9.
31. Myerson SG, Mitchell AR, Ormerod OJ, Banning AP. What is the role of balloon dilatation for severe aortic stenosis during pregnancy? J Heart Valve Dis. 2005;14:147-50.
32. Hung L, Rahimtoola SJ. Prosthetic heart valves and pregnancy. Circulation. 2003;107:1240-6.
33. Butchart EG, Gohlke-Barwolf C, Antunes MJ, Tornos P, De Caterina R, Cormier B, et al; Working Groups on Valvular Heart Disease, Thrombosis, and Cardiac Rehabilitation and Exercise Physiology, European Society of Cardiology. Recommendations for the management of patients after heart valve surgery. Eur Heart J. 2005;26:2463-71.
34. Seshadri N, Goldhaber SZ, Elkayam U, Grimm RA, Groce JB 3rd, Heit JA, et al. The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients. Am Heart J. 2005;150:27-34.